Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1898 1
1947 1
1953 1
1960 1
1961 4
1962 1
1963 2
1965 1
1967 3
1969 2
1970 1
1971 7
1972 1
1973 2
1975 1
1976 1
1977 6
1978 3
1979 4
1980 4
1981 9
1982 2
1983 2
1984 3
1985 7
1986 5
1987 3
1988 15
1989 6
1990 4
1991 8
1992 4
1993 2
1994 5
1995 8
1996 2
1997 4
1998 3
1999 3
2000 6
2001 7
2002 7
2003 5
2004 9
2005 2
2006 4
2007 7
2008 2
2009 9
2010 7
2011 7
2012 12
2013 12
2014 12
2015 7
2016 18
2017 21
2018 21
2019 24
2020 24
2021 26
2022 28
2023 31
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

419 results

Results by year

Filters applied: . Clear all
Page 1
Microvascular stabilization via blood-brain barrier regulation prevents seizure activity.
Greene C, Hanley N, Reschke CR, Reddy A, Mäe MA, Connolly R, Behan C, O'Keeffe E, Bolger I, Hudson N, Delaney C, Farrell MA, O'Brien DF, Cryan J, Brett FM, Beausang A, Betsholtz C, Henshall DC, Doherty CP, Campbell M. Greene C, et al. Among authors: connolly r. Nat Commun. 2022 Apr 14;13(1):2003. doi: 10.1038/s41467-022-29657-y. Nat Commun. 2022. PMID: 35422069 Free PMC article.
The future of Blue Carbon science.
Macreadie PI, Anton A, Raven JA, Beaumont N, Connolly RM, Friess DA, Kelleway JJ, Kennedy H, Kuwae T, Lavery PS, Lovelock CE, Smale DA, Apostolaki ET, Atwood TB, Baldock J, Bianchi TS, Chmura GL, Eyre BD, Fourqurean JW, Hall-Spencer JM, Huxham M, Hendriks IE, Krause-Jensen D, Laffoley D, Luisetti T, Marbà N, Masque P, McGlathery KJ, Megonigal JP, Murdiyarso D, Russell BD, Santos R, Serrano O, Silliman BR, Watanabe K, Duarte CM. Macreadie PI, et al. Among authors: connolly rm. Nat Commun. 2019 Sep 5;10(1):3998. doi: 10.1038/s41467-019-11693-w. Nat Commun. 2019. PMID: 31488846 Free PMC article. Review.
Chemonucleolysis.
Connolly RC. Connolly RC. J Bone Joint Surg Br. 1977 Feb;59(1):1. doi: 10.1302/0301-620X.59B1.845224. J Bone Joint Surg Br. 1977. PMID: 845224 No abstract available.
Improving the management of self-harm in primary care.
Mughal F, Clarke L, Connolly R, Lee AYT, Quinlivan L, Kapur N. Mughal F, et al. Among authors: connolly r. Br J Gen Pract. 2023 Mar 30;73(729):148-149. doi: 10.3399/bjgp23X732297. Print 2023 Apr. Br J Gen Pract. 2023. PMID: 36997200 Free PMC article. No abstract available.
Global bioanalytical support.
John Lin Z, Zhang T, Pasas-Farmer S, Brooks SD, Moyer M, Connolly R. John Lin Z, et al. Among authors: connolly r. Bioanalysis. 2014 May;6(10):1349-56. doi: 10.4155/bio.14.101. Bioanalysis. 2014. PMID: 24958119
Treatment of HER2-positive breast cancer.
Figueroa-Magalhães MC, Jelovac D, Connolly R, Wolff AC. Figueroa-Magalhães MC, et al. Among authors: connolly r. Breast. 2014 Apr;23(2):128-136. doi: 10.1016/j.breast.2013.11.011. Epub 2013 Dec 19. Breast. 2014. PMID: 24360619 Free PMC article. Review.
Antibiotics for otitis media with effusion (OME) in children.
Mulvaney CA, Galbraith K, Webster KE, Rana M, Connolly R, Marom T, Daniel M, Venekamp RP, Schilder AG, MacKeith S. Mulvaney CA, et al. Among authors: connolly r. Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD015254. doi: 10.1002/14651858.CD015254.pub2. Cochrane Database Syst Rev. 2023. PMID: 37870130 Review.
COVID-19 recovery can benefit biodiversity.
Pearson RM, Sievers M, McClure EC, Turschwell MP, Connolly RM. Pearson RM, et al. Among authors: connolly rm. Science. 2020 May 22;368(6493):838-839. doi: 10.1126/science.abc1430. Science. 2020. PMID: 32439784 No abstract available.
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial.
Luke JJ, Patel MR, Blumenschein GR, Hamilton E, Chmielowski B, Ulahannan SV, Connolly RM, Santa-Maria CA, Wang J, Bahadur SW, Weickhardt A, Asch AS, Mallesara G, Clingan P, Dlugosz-Danecka M, Tomaszewska-Kiecana M, Pylypenko H, Hamad N, Kindler HL, Sumrow BJ, Kaminker P, Chen FZ, Zhang X, Shah K, Smith DH, De Costa A, Li J, Li H, Sun J, Moore PA. Luke JJ, et al. Among authors: connolly rm. Nat Med. 2023 Nov;29(11):2814-2824. doi: 10.1038/s41591-023-02593-0. Epub 2023 Oct 19. Nat Med. 2023. PMID: 37857711 Free PMC article. Clinical Trial.
419 results